您的位置: 首页 > 农业专利 > 详情页

ANGIOPOIETIN-2拮抗劑與VEGF-A、KDR和/或FLTL拮抗劑結合用於治療癌症
专利权人:
MEDIMMUNE LIMITED
发明人:
BROWN, JEFFREY, LESTER,EMERY, STEPHEN, CHARLES,BLAKEY, DAVID, CHARLES
申请号:
HK08112903.3
公开号:
HK1121674B
申请日:
2008.11.25
申请国别(地区):
HK
年份:
2013
代理人:
摘要:
The invention relates to agents which possess anti-angiogenic activity and are accordingly useful in methods of treatment of disease states associated with angiogenesis in the animal or human body. More specifically the invention concerns a combination of an antagonist of the biological activity of Angiopoietin-2 and an antagonist of the biological activity of VEGF-A, and/or KDR, and/or Flt1, and uses of such antagonists.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充